| Filename | HC-HIV.compressed.pdf |
| filesize | 632.38 kB |
| Version | 1 |
| Date added | March 9, 2017 |
| Downloaded | 864 times |
| Category | Press Statements |
| Tags | 103, 104, 112, 132, 133, 154 |
On March 2, 2017, World Health Organization (WHO), released updated recommendations concerning the use of hormonal contraceptive methods by women at high risk of HIV. The recommendations for use of progestogen-only injectables (DMPA) among women at high risk of HIV changed from Medical Eligibility Criteria (MEC) 1* to MEC 2. Recommendations for all other methods of hormonal contraception remained unchanged.
